MicroRNAs in Inflammatory Bowel Disease and Its Complications
Open Access
- 6 August 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (15) , 8751
Abstract
Inflammatory bowel disease (IBD), classified primarily between Crohn’s disease and ulcerative colitis, is a collection of chronic gastrointestinal inflammatory conditions that cause multiple complications because of systemic alterations in the immune response. One major player is microRNA (miRNA), which is found to be associated with multiple pathways in mediating inflammation, especially those of a chronic nature in IBD, as well as irritable bowel syndrome. Although there have been studies linking miRNA alterations in IBD, even differentiating Crohn’s disease and ulcerative colitis, this review focuses mainly on how miRNAs cause and mechanistically influence the pathologic complications of IBD. In addition to its role in the well-known progression towards colorectal cancer, we also emphasize how miRNA manifests the many extraintestinal complications in IBD such as cardiovascular diseases; neuropsychiatric conditions such as depression and anxiety disorders; and others, including various musculoskeletal, dermatologic, ocular, and hepatobiliary complications. We conclude through a description of its potential use in bettering diagnostics and the future treatment of IBD and its systemic symptoms.Keywords
Funding Information
- National Institutes of Health (R01 HL152683)
This publication has 99 references indexed in Scilit:
- Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in RemissionGastroenterology Research and Practice, 2013
- MicroRNA function and neurotrophin BDNFNeurochemistry International, 2011
- Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidencesInternational Journal of Colorectal Disease, 2011
- Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohnʼs diseaseInflammatory Bowel Diseases, 2011
- Identification of microRNAs associated with ileal and colonic Crohnʼs disease†Inflammatory Bowel Diseases, 2010
- A Brief Review on the Mechanisms of miRNA RegulationGenomics, Proteomics & Bioinformatics, 2009
- MicroRNAs Are Differentially Expressed in Ulcerative Colitis and Alter Expression of Macrophage Inflammatory Peptide-2αGastroenterology, 2008
- Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell functionMucosal Immunology, 2008
- Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell RestitutionGastroenterology, 2005
- Murine TOLL-like Receptor 4 Confers Lipopolysaccharide Responsiveness as Determined by Activation of NFκB and Expression of the Inducible CyclooxygenaseJournal of Biological Chemistry, 2000